Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bausch Health Cos Inc. (BHC) had Revenue of $10.27B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$10.27B
Net Income	$157.00M
Cost of Goods Sold	$3.01B
Gross Profit	$7.25B
Operating Expenses	$8.45B
Operating Income	$1.81B
Non-Operating Income/Expense	$-1.45B
Pre-Tax Income	$367.00M
Normalized Pre-Tax Income	$367.00M
Income after Taxes	$120.00M
Income from Continuous Operations	$120.00M
Consolidated Net Income/Loss	$120.00M
Normalized Income after Taxes	$120.00M
EBIT	$1.81B
EBITDA	$3.12B
Weighted-Average Shares Outstanding (Basic)	370.90M
Weighted-Average Shares Outstanding (Diluted)	375.00M
Earnings per Share (EPS) (Basic)	$0.42
Earnings per Share (EPS) (Diluted)	$0.42
Balance Sheet Financials
Current Assets	$6.16B
Property, Plant, and Equipment	$2.07B
Long-Term Assets	$20.21B
Total Assets	$26.37B
Current Liabilities	$4.18B
Long-Term Debt	$20.61B
Long-Term Liabilities	$21.81B
Total Liabilities	$25.99B
Common Equity	$377.00M
Tangible Shareholders Equity	$-15.54B
Shareholders Equity	$377.00M
Common Shares Outstanding	370.53M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.40B
Cash Flow from Investing Activities	$-595.00M
Cash Flow from Financial Activities	$-742.00M
Beginning Cash	$1.20B
End Cash	$1.32B
Increase/Decrease in Cash	$124.00M
Stock-Based Compensation	$216.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.47
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.98
Debt to Equity Ratio	55.31
Gross Margin	70.65%
Operating Margin	17.66%
EBIT Margin	17.66%
EBITDA Margin	30.34%
Pre-Tax Profit Margin	3.57%
Profit Margin	1.53%
Free Cash Flow	$1.00B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.39
Inventory Turnover	1.85
Receiveable Turnover	4.37
Days Sales in Receivables	83.59
Return on Equity	31.83%
Return on Tangible Equity	-0.77%
Return on Assets	0.46%
Return on Investments	0.57%
Book Value Per Share	$1.02
Free Cash Flow per Share	$2.67
Operating Cash Flow per Share	$3.73

Data from Zacks Investment Research, Inc.